Borski Fund

Borski Fund, established in 2019 and headquartered in Amsterdam, Netherlands, is a venture capital firm dedicated to addressing the investment diversity gap, particularly in the context of female entrepreneurship. The firm is founded on the belief that female entrepreneurs often achieve superior results compared to their male counterparts, despite receiving a disproportionately low share of venture capital funding. Borski Fund focuses on improving access to financing for women-led startups, especially those aiming to create a positive impact in the world. The firm primarily invests in the retail and healthtech sectors, seeking to support innovative businesses that align with its mission of fostering diversity and promoting sustainable growth.

Simone Brummelhuis

Fund Director and Partner

Dagmar Claasen

Venture Partner

Anieke Lamers

Venture Partner

Daphne Postma

Junior Partner

Floortje Rasenberg

Venture Partner

Aletta Stas-Bax

Venture Partner

19 past transactions

Antennex

Venture Round in 2025
We develop compact measurement equipment for next-generation wireless systems. We speed up measurement time and make complicated measurements easy with smart algorithms.

CarbonX

Venture Round in 2024
CarbonX B.V., based in Amsterdam, the Netherlands, specializes in the manufacturing of carbon networks. The company's innovative products are utilized across various industries, including elastomers, automotive and aerospace thermoplastics, construction, energy, and sports and leisure thermosets. By developing and supplying advanced materials, CarbonX aims to contribute to the evolution of next-generation materials that meet the demands of modern applications.

CarbonX

Venture Round in 2024
CarbonX B.V., based in Amsterdam, the Netherlands, specializes in the manufacturing of carbon networks. The company's innovative products are utilized across various industries, including elastomers, automotive and aerospace thermoplastics, construction, energy, and sports and leisure thermosets. By developing and supplying advanced materials, CarbonX aims to contribute to the evolution of next-generation materials that meet the demands of modern applications.

DUDE CHEM

Seed Round in 2024
DUDE CHEM is a green chemical manufacturing company focused on transforming the pharmaceutical and chemical industries into environmentally responsible sectors. The company utilizes advanced technology in computational chemistry and digitalization, alongside its expertise in green chemistry, to optimize resource use and enhance production processes. DUDE CHEM's innovative approach allows for the reuse of costly materials, accelerates the design and scaling of chemical synthesis, and monitors production processes to maintain high standards of quality and efficiency. By providing clients with sustainable alternatives, DUDE CHEM aims to promote greener practices in pharmaceutical production while ensuring operational efficiency.

Soft Revolt

Seed Round in 2023
Soft Revolt is a women's store that sells wireless sustainable bralettes, and kimonos in stores and online.

RTI Blockchain

Seed Round in 2023
Blockchain-based load carrier management company

The Selection Lab

Seed Round in 2023
The Selection Lab is a hiring platform that specializes in providing online assessments to objectively quantify predictors related to candidate selection. By offering validated assessments, the platform aids businesses in making informed hiring decisions that promote diversity and reduce bias in the recruitment process. The Selection Lab's approach allows organizations to streamline their hiring practices while ensuring a fair evaluation of potential candidates.

Thirona

Series B in 2023
Thirona is a software solutions company specializing in automated analysis tools for the healthcare sector, particularly in medical imaging. The firm employs artificial intelligence to create software products that focus on the analysis of thoracic CT scans, chest X-rays, and retinal images. In addition to its software offerings, Thirona provides certified image analysis services that deliver accurate and repeatable measurements from medical images. This enables hospitals to detect and address diseases more efficiently, ultimately enhancing patient care and outcomes.

VIVOLTA

Series A in 2023
VIVOLTA specializes in the contract development and manufacturing of electrospun medical products, focusing on nanofiber-based solutions that promote the body's natural healing processes. The company has developed advanced electrospinning technologies that enable the production of medical implants, effectively replicating the human extracellular matrix in a reproducible and scalable manner. VIVOLTA's offerings include various methods such as melt electrospinning, wet electrospinning, and emulsion electrospinning, along with specialized modules and tools that enhance the efficiency of electrospinning research. Through these innovations, VIVOLTA supports medical professionals in advancing their medical concepts and improving patient outcomes.

Aiir Innovations

Venture Round in 2023
Aiir Innovations B.V., founded in 2016 and based in Amsterdam, specializes in developing software solutions that enhance industrial processes through artificial intelligence and computer vision. The company focuses on automating borescope inspection analysis, which significantly improves the efficiency and quality of visual inspections in the aviation sector. Their software analyzes video footage and images to assist inspection teams, enabling them to identify anomalies such as cracks and dents in aircraft engines. This automation allows mechanics to concentrate on assessing damage rather than the inspection process itself, ultimately contributing to safer aircraft operations. Aiir Innovations aims to broaden the application of its technology beyond aviation, enhancing maintenance practices across various industries.

Parfumado

Seed Round in 2022
Parfumado specializes in providing a diverse selection of perfumes and personal items through a subscription model. The company utilizes data and a unique algorithm to offer personalized fragrance recommendations tailored to individual preferences. By operating on a monthly membership basis, Parfumado enables customers to explore a wide array of scents, ensuring they have access to fragrances that meet their personal needs for everyday use.

Closure

Series A in 2022
Closure offers a subscription management platform aimed at simplifying the process of handling subscriptions and accounts after an individual's death. The company enables users to register on its platform and specify their preferences for each service, allowing them to choose whether to terminate or transfer subscriptions to another person. By streamlining the management of accounts, contracts, and subscriptions, Closure aims to alleviate the burden on relatives during a difficult time, ensuring that all necessary actions related to inheritance are completed efficiently. This innovative approach seeks to bring clarity and ease to a traditionally complex process in the private sector, mirroring the more straightforward procedures often found in the public sector.

inne

Series A in 2022
Inne is a Berlin-based biotech startup that builds a hormone-based mini lab for women with a mission to make natural contraception convenient and accurate. They aim to help women tune into their bodies and make informed decisions about their fertility and overall female health. Inne uses biochemistry and an app to track hormones and understand what it means and how they affect a woman's everyday fertility.

Prolira BV

Venture Round in 2022
Prolira BV is a Dutch company based in Utrecht that specializes in developing medical technology for the early detection of delirium, an acute brain failure condition. Founded in 2015, Prolira has introduced DeltaScan, an EEG-based device designed to monitor brain activity and facilitate timely treatment for patients at risk of acute encephalopathy and delirium. The DeltaScan system comprises a single-use electrode patch, known as the DeltaScan Patch, and the DeltaScan Monitor, which employs a validated proprietary algorithm to analyze EEG data. This innovative approach aims to enhance patient recovery by supporting clinicians in identifying and addressing delirium, a condition that affects approximately 20 million patients annually in hospitals across Europe and the United States, leading to significant cognitive impairment and increased healthcare costs.

Thirona

Venture Round in 2021
Thirona is a software solutions company specializing in automated analysis tools for the healthcare sector, particularly in medical imaging. The firm employs artificial intelligence to create software products that focus on the analysis of thoracic CT scans, chest X-rays, and retinal images. In addition to its software offerings, Thirona provides certified image analysis services that deliver accurate and repeatable measurements from medical images. This enables hospitals to detect and address diseases more efficiently, ultimately enhancing patient care and outcomes.

The Next Closet

Venture Round in 2021
The Next Closet is an online peer-to-peer marketplace based in the Netherlands that specializes in secondhand designer clothes and accessories. The platform allows users to sell their unused fashion items while providing customers with access to unique pieces at competitive prices. By promoting the resale of high-quality fashion, The Next Closet aims to foster sustainable consumption and reduce waste in the fashion industry. This initiative not only helps individuals declutter their wardrobes but also offers shoppers the opportunity to discover distinctive styles from various sellers. Through its innovative approach, The Next Closet positions itself as a leader in the sustainable fashion movement.

Atlantic Therapeutics Limited

Venture Round in 2021
Atlantic Therapeutics Limited is a medical technology company specializing in the development and distribution of devices for pelvic floor muscle strengthening and nerve stimulation. The company offers Innovotherapy, a device that addresses these needs, as well as INNOVO, a wearable solution designed specifically for treating stress urinary incontinence, a common cause of bladder weakness. Established in 2013, Atlantic Therapeutics is headquartered in Galway, Ireland, with additional offices in London, Paris, and Salem, Germany. Its products are distributed across Ireland, the United Kingdom, France, Germany, and the Middle East. Atlantic Therapeutics operates as a subsidiary of Bio-Medical Research Limited.

VIVOLTA

Venture Round in 2020
VIVOLTA specializes in the contract development and manufacturing of electrospun medical products, focusing on nanofiber-based solutions that promote the body's natural healing processes. The company has developed advanced electrospinning technologies that enable the production of medical implants, effectively replicating the human extracellular matrix in a reproducible and scalable manner. VIVOLTA's offerings include various methods such as melt electrospinning, wet electrospinning, and emulsion electrospinning, along with specialized modules and tools that enhance the efficiency of electrospinning research. Through these innovations, VIVOLTA supports medical professionals in advancing their medical concepts and improving patient outcomes.

Ziel

Series A in 2020
Ziel, Inc. PBC, founded in 2015 and based in New York, specializes in the design, manufacturing, and retail of athletic apparel. The company focuses on creating apparel that supports athletes in their fitness pursuits. Ziel offers on-demand athletic apparel produced in the USA, utilizing machine learning technology to generate custom brand designs. This innovative approach allows athletes to browse, discover, and purchase a variety of sports apparel and accessories tailored to their needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.